59.4%United States United States
8.7%United Kingdom United Kingdom
5%Canada Canada
4%Australia Australia
3.5%Philippines Philippines
2.6%Netherlands Netherlands
2.4%India India
1.6%Germany Germany
1%France France
0.7%Poland Poland

Today: 214
Yesterday: 251
This Week: 214
Last Week: 2221
This Month: 4802
Last Month: 6796
Total: 129401

Study: Marijuana compound helps mitigate cocaine addiction in mice


Drug Abuse

Study: Marijuana compound helps mitigate cocaine addiction in mice

By Stephen C. Webster

Tuesday, July 26th, 2011

Researchers in Maryland and Beijing have learned that a component marijuana helps mitigate cocaine addiction in mice, leading some to hope that marijuana may one day become the next big anti-addiction therapy.

The discovery was announced in .

The study found that cannabidiol, an active component of marijuana that does not produce an inebriating effect, effectively turns down a receptor in the brain that is stimulated by cocaine.

Scientists used a synthetic version of cannabidiol, called JWH-133, to see how mice given regular doses of cocaine would respond. They found that mice given JWH-133 dramatically reduced their cocaine intake by up to 60 percent.

Their success in reducing cocaine consumption in mice may lead to new drug replacement therapies for cocaine and crack addiction, helping addicts detox and overcome withdrawal symptoms much like methadone therapy sometimes prescribed to heroin addicts.

As a recreational drug, marijuana produces less dependence and withdrawal effects than even caffeine. Cocaine is  and produces a strong reinforcing effect that makes a user more likely to use the drug again.

JWH-133 is closely related to JWH-018, which has been the subject of recent controversy for its appearance in "Spice" and other herbal smoking blends purported to produce marijuana-like highs. While JWH-133 does not produce such effects, JWH-018 and other similar test chemicals do, leading the Drug Enforcement Administration to place a series of them on their list of controlled substances.

The , an independent agency set up by the United Nations, that banning JWH-018 was a positive step in drug control efforts, but urged industrialized nations to go further and also adopt blanket bans on new substances to prevent the rise of new designer drugs -- a policy recommendation that, if adopted, would also apply to JWH-133.

(H/T: )